Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G)

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Benayoun, Bérénice A ^a,b   Caburet, Sandrine ^a,b   Dipietromaria, Aurélie ^a,b   Georges, Adrien ^a,b,c   D'Haene, Barbara ^d   Pandaranayaka, P J Eswari ^e   L'Hôte, David ^a,b   Todeschini, Anne Laure ^a,b   Krishnaswamy, Sankaran ^e   Fellous, Marc ^f   De Baere, Elfride ^d   Veitia, Reiner A ^a,b  

^a INSTITUT JACQUES MONOD   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ECOLE NORMALE SUPÉRIEURE   (France)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e MADURAI KAMARAJ UNIVERSITY   (India)

^f INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; HOMODIMER; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FOXL2; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG; WT PROTEIN; WT1 PROTEIN; CYSTEINE; FOXL2 PROTEIN, HUMAN; TRYPTOPHAN;

ADULT; ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; OPEN READING FRAME; OXIDATIVE STRESS; PROTEIN INTERACTION; SOMATIC MUTATION; WILD TYPE; AMINO ACID SEQUENCE; CELL FRACTIONATION; CHEMICAL STRUCTURE; CHEMISTRY; FEMALE; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; OVARY TUMOR; PHYSIOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ADULT; AMINO ACID SEQUENCE; CELL LINE, TUMOR; CYSTEINE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOSA CELL TUMOR; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; OPEN READING FRAMES; OVARIAN NEOPLASMS; SUBCELLULAR FRACTIONS; TRANSCRIPTIONAL ACTIVATION; TRYPTOPHAN;

EID: 77649301128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008789     Document Type: Article

References (44)

1. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al. (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/ epicanthus inversus syndrome. Nat Genet 27: 159-166.
2. Zlotogora J, SagiM, Cohen T (1983) The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet 35: 1020-1027.
3. Cocquet J, De Baere E, Gareil M, Pannetier M, Xia X, et al. (2003) Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet Genome Res 101: 206-211.
4. Cocquet J, Pailhoux E, Jaubert F, Servel N, Xia X, et al. (2002) Evolution and expression of FOXL2. J Med Genet 39: 916-921.
5. Ellsworth BS, Egashira N, Haller JL, Butts DL, Cocquet J, et al. (2006) FOXL2 in the pituitary: molecular, genetic, and developmental analysis. Mol Endocrinol 20: 2796-2805.
6. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, et al. (1998) Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12: 1691-1704.
7. Moumne L, Batista F, Benayoun BA, Nallathambi J, Fellous M, et al. (2008) The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol 282: 2-11.
8. Benayoun BA, Kalfa N, Sultan C, Veitia RA (2009) The forkhead factor FOXL2: A novel tumor suppressor? Biochim Biophys Acta. DOI: 10.1016/j.bbcan. 2009.09.002.
9. D'Haene B, Attanasio C, Beysen D, Dostie J, Lemire E, et al. (2009) Disease-causing 7.4 kb cis-regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening. PLoS Genet 5: e1000522.
10. Beysen D, De Jaegere S, Amor D, Bouchard P, Christin-Maitre S, et al. (2008) Identification of 34 novel and 56 known FOXL2 mutations in patients with Blepharophimosis syndrome. Hum Mutat 29: E205-219.
11. Kalfa N, Philibert P, Patte C, Ecochard A, Duvillard P, et al. (2007) Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril 87: 896-901.
12. Shah SP, Kobel M, Senz J, Morin RD, Clarke BA, et al. (2009) Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary. N Engl J Med 360: 2719-2729.
13. Pectasides D, Pectasides E, Psyrri A (2008) Granulosa cell tumor of the ovary. Cancer Treat Rev 34: 1-12.
14. Kalfa N, Patte C, Orbach D, Lecointre C, Pienkowski C, et al. (2005) A nationwide study of granulosa cell tumors in pre- and postpubertal girls: missed diagnosis of endocrine manifestations worsens prognosis. J Pediatr Endocrinol Metab 18: 25-31.
15. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, et al. (2007) Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3: 1709-1723.
16. Nishi Y, Yanase T, Mu Y, Oba K, Ichino I, et al. (2001) Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142: 437-445.
17. Rigourd V, Chelbi S, Chauvet C, Rebourcet R, Barbaux S, et al. (2009) Re-evaluation of the role of STOX1 transcription factor in placental development and preeclampsia. J Reprod Immunol 82: 174-181.
18. Liu Y, Bodmer WF (2006) Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc Natl Acad Sci U S A 103: 976-981.
19. Schrader KA, Gorbatcheva B, Senz J, Heravi-Moussavi A, Melnyk N, et al. (2009) The Specificity of the FOXL2 c.402C.G Somatic Mutation: A Survey of Solid Tumors. PLoS ONE 4: e7988.
20. Beysen D, Raes J, Leroy BP, Lucassen A, Yates JR, et al. (2005) Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet 77: 205-218.
21. Qian X, Shu A, Qin W, Xing Q, Gao J, et al. (2004) A novel insertion mutation in the FOXL2 gene is detected in a big Chinese family with blepharophimosisptosis-epicanthus inversus. Mutat Res 554: 19-22.
22. Perreault N, Sackett SD, Katz JP, Furth EE, Kaestner KH (2005) Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon. Genes Dev 19: 311-315.
23. Beysen D, Moumne L, Veitia R, Peters H, Leroy BP, et al. (2008) Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalisation, protein aggregation and impaired transactivation. Hum Mol Genet 17: 2030-2038.
24. Caburet S, Demarez A, Moumne L, Fellous M, De Baere E, et al. (2004) A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J Med Genet 41: 932-936.
25. Moumne L, Dipietromaria A, Batista F, Kocer A, Fellous M, et al. (2008) Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. Hum Mol Genet 17: 1010-1019.
26. Nallathambi J, Laissue P, Batista F, Benayoun BA, Lesaffre C, et al. (2008) Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients. Hum Mutat 29: E123-E131.
27. Dipietromaria A, Benayoun BA, Todeschini AL, Rivals I, Bazin C, et al. (2009) Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems. Hum Mol Genet 18: 3324-3333.
28. Laissue P, Lakhal B, Benayoun BA, Dipietromaria A, Braham R, et al. (2009) Functional evidence implicating FOXL2 in non syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. J Med Genet 46: 455-457.
29. Ellsworth BS, Burns AT, Escudero KW, Duval DL, Nelson SE, et al. (2003) The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein. Mol Cell Endocrinol 206: 93-111.
30. Litichever N, Gershon E, Dekel N, Koch Y (2009) Hormonal regulation of GnRH and LHbeta mRNA expression in cultured rat granulosa cells. J Mol Neurosci 39: 78-85.
31. Grundker C, Gunthert AR, Millar RP, Emons G (2002) Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 87: 1427-1430.
32. Blount AL, Schmidt K, Justice NJ, Vale WW, Fischer WH, et al. (2009) FoxL2 and Smad3 coordinately regulate follistatin gene transcription. J Biol Chem 284: 7631-7645.
33. Kim SG, Kim HA, Jong HS, Park JH, Kim NK, et al. (2005) The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell 16: 4672-4683.
34. Benayoun BA, Batista F, Auer J, Dipietromaria A, L'Hote D, et al. (2009) Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations. Hum Mol Genet 18: 632-644.
35. Benayoun BA, Dipietromaria A, Bazin C, Veitia RA (2009) FOXL2: At the Crossroads of Female Sex Determination and Ovarian Function. In: Maiese K, ed. Forkhead Transcription Factors: Vital Elements in Biology and Medicine. Austin: Landes Biosciences. pp 207-226.
36. Murdoch WJ (2005) Carcinogenic potential of ovulatory genotoxicity. Biol Reprod 73: 586-590.
37. Stroud JC, Wu Y, Bates DL, Han A, Nowick K, et al. (2006) Structure of the forkhead domain of FOXP2 bound to DNA. Structure 14: 159-166.
38. Obsil T, Obsilova V (2008) Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 27: 2263-2275.
39. Hamelin V, Letourneux C, Romeo PH, Porteu F, Gaudry M (2006) Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation. Blood 107: 3106-3113.
40. Pannetier M, Fabre S, Batista F, Kocer A, Renault L, et al. (2006) FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol 36: 399-413.
41. Kim HP, Roe JH, Chock PB, Yim MB (1999) Transcriptional activation of the human manganese superoxide dismutase gene mediated by tetradecanoylphorbol acetate. J Biol Chem 274: 37455-37460.
42. Benayoun BA, Caburet S, Dipietromaria A, Bailly-Bechet M, Fellous M, et al. (2008) The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles. Hum Mol Genet 17: 3118-3127.
43. Kawai S, Kato T, Inaba H, Okahashi N, Amano A (2005) Odd-skipped related 2 splicing variants show opposite transcriptional activity. Biochem Biophys Res Commun 328: 306-311.
44. Sambrook J, Russell DW (2001) Molecular Cloning - A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press.